GlassScriptPhysician profile
Sean D Fuller
NPI 1063488054
$6,628.52
in general payments reported to CMS, 2019-2025
55 companies · $1,487 in 2025
The $1,487 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $599 · 2021: $1,116 · 2022: $885 · 2023: $771 · 2024: $1,535 · 2025: $1,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,792.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.46 | 2021-2025 | |
| Novo Nordisk INC | $446.09 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $413.58 | 2021-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $402.93 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $384.94 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $323.65 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $288.74 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $263.22 | 2019-2025 | Spravato |
| Dexcom, INC. | $226.92 | 2024-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $171.44 | 2023-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Corcept Therapeutics | $171.40 | 2024-2025 | Korlym |
| Amgen INC. | $169.76 | 2019-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.48 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.62 | 2020-2022 | |
| Lilly USA, LLC | $147.06 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $144.75 | 2020-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $138.86 | 2022 | |
| Exact Sciences Corporation | $115.83 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $113.41 | 2021 | |
| Medtronic, INC. | $103.09 | 2024-2025 | Intellis Adaptivestim |
| Upsher-Smith Laboratories LLC | $92.30 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $88.68 | 2024-2025 | Zenpep |
| Esperion Therapeutics, INC. | $79.42 | 2021-2022 | |
| Pfizer INC. | $71.77 | 2020-2024 | |
| Recor Medical INC | $69.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Jazz Pharmaceuticals INC. | $68.21 | 2020-2022 | |
| Intra-Sana Laboratories | $66.29 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Takeda Pharmaceuticals U.S.A., INC. | $63.01 | 2021-2022 | |
| Inari Medical, INC. | $62.21 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $51.96 | 2019-2024 | Dificid |
| Glaxosmithkline, LLC. | $46.79 | 2020-2023 | Shingrix, Arexvy |
| Endo Pharmaceuticals INC. | $43.94 | 2020 | |
| Antares Pharma, INC. | $42.43 | 2019-2025 | Xyosted |
| Astellas Pharma US INC | $39.88 | 2019-2020 | |
| Axsome Therapeutics, INC. | $37.51 | 2022-2024 | Sunosi |
| Arbor Pharmaceuticals, INC. | $36.10 | 2020-2021 | |
| Mannkind Corporation | $35.70 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $32.56 | 2020 | |
| Genentech USA, INC. | $27.40 | 2020-2021 | |
| Allergan, INC. | $25.85 | 2020 | |
| Sanofi-Aventis U.S. LLC | $25.44 | 2020-2022 | |
| Irhythm Technologies, INC. | $25.41 | 2019 | |
| Ascensia Diabetes Care US INC. | $24.36 | 2024 | |
| Stryker Corporation | $21.93 | 2025 | Clottriever Bold Catheter |
| Noven Therapeutics, LLC | $21.63 | 2024 | Xelstrym |
| Aytu Biopharma, INC. | $20.09 | 2019 | |
| Sumitomo Pharma America, INC. | $19.75 | 2025 | Gemtesa |
| Lundbeck LLC | $17.65 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $16.89 | 2021 | |
| Xeris Pharmaceuticals, INC. | $14.76 | 2023 | Gvoke Hypopen |
| Bausch Health US, LLC | $14.52 | 2022 | |
| Edwards Lifesciences Corporation | $14.44 | 2022 | |
| Cvrx, INC. | $13.45 | 2024 | Barostim Neo System |
| Intercept Pharmaceuticals, INC. | $12.79 | 2019 | |
| Intersect Ent, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.